Drugs / HyperRAB ST
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02956746 Comparator | Aug 2016 → Dec 2017 | rabies | Synermore Biologics Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HyperRAB ST | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02956746 ↗ |
| Modality | Protein / enzyme biologic | “HyperRAB ST (human rabies immune globulin)” NCT02956746 ↗ |